Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
The deal would allow J&J to resolve the lawsuits through a third bankruptcy filing of a subsidiary company, LTL Management.
-
US challenges ‘bogus' patents on Ozempic and other drugs in effort to spur competition
Federal regulators on Tuesday sent warning letters to several drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other respiratory conditions.
-
Is there a ‘facility fee' on your medical bill? Here's what to know about the charge
The next time you receive a medical bill, take a close look at it line by line. A certain type of fee is popping up on more and more bills, and experts say it can range anywhere from a couple bucks to... -
Mammograms should start at 40 to address rising breast cancer rates at younger ages, new guidelines says
The U.S. Preventive Services Task Force announced the updated guidance Tuesday
-
Less alcohol, or none at all, is one path to better health
Moderate drinking was once thought to have benefits for the heart. But better research methods have thrown cold water on that idea.